GnRH agonists suppress sex steroid levels and are used as an adjuvant treatment of hormone-sensitive tumors, such as prostate or breast cancer (Chengalvala et al., 2003; Huhtaniemi et al., 2009). The gene discussed is GNRH1; the disease is breast carcinoma.